Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
ACST
Asymptomatic Carotid Surgery Trial



Principal Investigator
Alison Halliday

PI Address
Miss Alison Halliday, MS FRCS
Consultant Vascular Surgeon
Honorary Senior Lecturer
Department of Cardiological Sciences
St George’s Hospital Medical School
Cranmer Terrace
London SW17 0RE
Tel: +44 (0)20 8725 3746

Contact Address
Steven Robertson, Trial Manager
Phone +44(0) 20 8725-3746. Fax +44(0)20 8725-3782.
E-mail acst@sgul.ac.uk

ACST Office
Department of Cardiological Sciences
St Georges Hospital Medical School
Cranmer Terrace
London SW17 0RE
UK

Contact Email
acst@sgul.ac.uk

Sponsor



Study Size Actual:3120
Study Size Planned:3200
Centers Actual:126
Centers Planned:160
Max Time from onset:6 Months
Follow-up Duration:10 Years
Status:
Randomization is complete with 5-year results published in May of 2004. Follow-up will continue through 2008. Commenced April 1993 (follow-up ongoing for publication of 10-year results in 2007/2008, but recruitment closed in 2003).

Purpose:
To compare the efficacy of carotid endarterectomy (CAE) performed in conjunction with best medical treatment (BMT) with that of BMT alone in prolonging stroke-free survival time in patients with asymptomatic carotid stenosis.

Interventions:
Endarterectomy, carotid
Surgical therapy to remove atherosclerotic plaque in narrowed carotid arteries.

Location(s):
Bulgaria, Cyprus, England, Germany, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, Yugoslavia

Year Started: 1993
Year Finished: 2008
Year Presented: 2008
Year Published: 2004


Design:
International, multi-center, prospective, randomized trial.

Inclusion Criteria
Patients with unilateral or bilateral carotid stenosis considered appropriate for surgery, who have experienced no ipsilateral transient ischemic attack (TIA), amaurosis fugax, or stroke within the past 6 months, who have no history of ipsilateral disabling stroke or severe contralateral stroke, and who have no clear indication or contraindication for CEA, will be eligible for this trial.

Exclusion Criteria
Patients whose carotid plaques are smooth, calcified, and not significantly stenotic, who have a severe, life-threatening comorbidity other than stroke, who have recent acute myocardial infarction (MI), intracerebral neoplasia, intracerebral aneurysm, or whose carotid arteries are restenosed following a previous CEA, will be excluded from this trial.

Patient Involvement:
Prior to enrollment, all patients will undergo Duplex sonography and a clinical interview. Eligible patients will be randomized to receive either BMT or BMT combined with CEA. Patients in the BMT group will receive as many of the following treatments as are indicated: smoking cessation counseling and treatment, antihypertensives (if blood pressure is consistently > 160/100 mmHg), screening and treatment for diabetes, screening and treatment for coronary artery disease, treatment for hyperlipidemia (if cholesterol is > 5.0 mmol/L), and anticoagulant or antiplatelet drugs. Patients in the BMT/CAE group will receive the same medical treatment as the BMT cohort, and will also undergo CAE as soon as possible after enrollment. All patients will undergo repeat carotid duplex scans and clinical interviews at 4 months post-randomization and annually thereafter, for a period of 5 years.

Primary Outcome:
Mortality rate, incidence of stroke, and carotid stenosis (measured by Duplex sonography) at 4 months, 1, 2, 3, 4, and 5 years post-randomization.

Results:
Comparing all patients randomized to immediate CEA versus all patients randomized to deferral (combining the perioperative events and non-perioperative strokes), the net 5 year stroke risks were 6.4% vs 11.8% for all strokes (net gain 5.4% [3.0-7.8], p < 0.0001) and 3.5% vs 6.1% for fatal or disabling strokes (net gain 2.5% [0.8-4.3], p < 0.004) and 2.1% vs 4.2% for only fatal strokes (net gain 2.1% [0.6-3.6], p=0.006). The risk of stroke or death within 30 days of CEA was 3.1% (95% CI 2.3-4.1). Comparing all patients excluding such perioperative events, the 5 year stroke risks were 3.8% vs 11% (gain 7.2% [95% CI 5.0-9.4], p<0.0001). Most of this gain was from carotid territoy ischemic strokes - 2.7% vs 9.5% (gain 6.8% [4.8-8.8], p<0.0001). Half of which were disabling or fatal - 1.6% vs 5.3% (gain 3.7% [2.1-5.2], p<0.0001).

The results were separately significant for males and females, those with 70-90% carotid artery narrowing on ultrasound, and for those under 65 and 65-74 years old.
Ten year results will be available in 2008.

Source of Information:
Published protocol, 1994. Abstracts of major ongoing stroke trials. Stroke. 1998; 29: 2225; Stroke. 2000;31:2536 Correspondence with trial coordinator (Feb, 2002). Lancet. 2004; 363: 1491-1502.
Abstract presented @ International Stroke Conference (February 2008).

Web Links and Publications:
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.
Lancet 2004; 363: 1491-1502.

Asymptomatic carotid stenosis in patients on medical treatment alone.
Eur J Vasc Endovasc Surg 2002 Jun;23(6):519-23

Vascular surgical society of Great Britain and Ireland: carotid angiography is used more selectively in the Asymptomatic Carotid Surgery Trial.
Br J Surg 1999 May;86(5):690-1

Prevalence of asymptomatic CT infarcts in the ongoing Asymptomatic Carotid Surgery Trial (ACST).
Int Angiol 1998 Sep;17(3):194-200

Are we detecting and operating on high risk patients in the asymptomatic carotid surgery trial? The Asymptomatic Carotid Surgery Trial Collaborators.
Eur J Vasc Endovasc Surg 1998 Jul;16(1):59-64

The prevalence of cerebral infarcts in the Asymptomatic Carotid Surgery Trial (ACST) in relation to prior contralateral symptoms.
Int Angiol. 1998 Sep;17(3):194-200.

The asymptomatic carotid surgery trial (ACST).
Int Angiol 1995 Mar;14(1):18-20

The Asymptomatic Carotid Surgery Trial (ACST). Rationale and design. Steering Committee.
Eur J Vasc Surg 1994 Nov;8(6):703-10

ACST-2
StrokeCenter.org

Asymptomatic Carotid Surgery Trial

This information last updated on: 6/19/2009

Reviewed on: 06/19/2009.

UID: 7

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009